Policy on Data Sharing, Transparency, and Reproducibility
Regeneration, Reconstruction & Restoration (Triple R) Journal is committed to fostering openness, transparency, and reproducibility in scientific research. To uphold the integrity and verifiability of published findings, all submissions must comply with the following standards:
1- Data Availability and Sharing
Authors are strongly encouraged and expected to make the raw data, analytical code, and materials supporting the findings of their study publicly accessible.
-Public Repositories: Datasets should be deposited in recognized, publicly accessible, and domain-specific or generalist repositories (e.g., Dryad, Zenodo, Figshare, NCBI) whenever possible. Alternatively, data may be provided as open-access supplementary material.
-Data Availability Statement (DAS): Every manuscript must include a mandatory “Data Availability Statement” prior to the References section. This statement must clearly indicate whether data are available, where they can be accessed, and any relevant access conditions or persistent identifiers (e.g., DOI).
Standard Examples:
"The datasets generated and/or analyzed during the current study are available in the [Repository Name] repository, [Persistent Link/DOI]."
"The data that support the findings of this study are available upon reasonable request from the corresponding author, subject to [e.g., institutional/legal restrictions]."
"Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study."
-Restrictions: Any legitimate confidentiality, legal, proprietary, or ethical constraints preventing data sharing must be explicitly justified in the Data Availability Statement and approved by the Editorial Office.
2- Methodological Rigor and Detailed Reporting
To enable accurate replication of experiments and verification of results, authors must provide comprehensive descriptions of all experimental procedures and analytical tools:
-Detailed specifications of equipment, hardware, and reagents (including manufacturers, catalog/lot numbers, and purity).
-Specific names and version numbers of software packages, algorithms, and statistical code used for data analysis.
-Full experimental parameters, sample sizes, inclusion/exclusion criteria, and randomization/blinding procedures.
3- Adherence to Reporting Guidelines
To ensure structured and transparent reporting, authors must follow the recognized reporting guidelines appropriate for their study design (endorsed by the EQUATOR Network):
CONSORT: For Randomized Controlled Trials.
PRISMA: For Systematic Reviews and Meta-Analyses.
STROBE: For Observational Studies (Cohort, Case-Control, Cross-Sectional).
ARRIVE: For Animal Research.
CARE: For Case Reports.
STARD / TRIPOD: For Diagnostic and Prognostic Studies.
Authors are encouraged or may be requested during submission to provide the completed checklist corresponding to their study type.
4- Prospective Study Registration
In accordance with ICMJE recommendations:
Clinical Trials: Prospective registration in a publicly accessible trial registry approved by the WHO or ICMJE (such as the Iranian Registry of Clinical Trials (https://irct.behdasht.gov.ir) mandatory.
The registry name and the unique clinical trial registration number must be stated in the manuscript's abstract and methods sections.
Systematic Reviews & Observational Studies: Registration in relevant registries (e.g., PROSPERO for systematic reviews) is strongly encouraged to reduce publication bias and promote research integrity.
5- Ethical Compliance and Approvals
All research involving human participants, human biological material, or vertebrate animals must comply with national and international ethical standards (e.g., the Declaration of Helsinki):
-Formal approval from the relevant Institutional Review Board (IRB) or Independent Ethics Committee must be obtained prior to initiating the study.
-The formal ethics approval code/number and the approving committee's name must be explicitly stated in the manuscript.
-Confirmation of obtained written informed consent from human participants (or legal guardians) must be clearly reported.